In tumor cells, LDHC contributes to metabolic reprogramming by driving aerobic glycolysis and promotes tumor cell invasion, migration, and proliferation through activation of the PI3K/Akt/GSK-3B signaling pathway [13, 14]. The gene discussed is LDHC; the disease is neoplasm.